Androgen deprivation therapy plus docetaxel and estramustine versus androgen deprivation therapy alone for high-risk localised prostate cancer (GETUG 12): a phase 3 randomised controlled trial
Karim Fizazi
,
Laura Faivre
,
François Lesaunier
,
Remy Delva
,
Gwenaëlle Gravis
,
et al.
Journal articles
hal-01914904v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Premature Ovarian Failure and Fertility in Long-Term Survivors of Hodgkin's Lymphoma: A European Organisation for Research and Treatment of Cancer Lymphoma Group and Groupe d'Étude des Lymphomes de l'Adulte Cohort Study
Marleen A.E. van Der Kaaij
,
Natacha Heutte
,
Paul Meijnders
,
Edwige Abeilard-Lemoisson
,
Michele Spina
,
et al.
Journal articles
hal-02358987v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
A phase II trial evaluating the efficacy and safety of efavirenz in metastatic castration-resistant prostate cancer
Nadine Houédé
,
M. Pulido
,
L. Mourey
,
F. Joly
,
J. M. Ferrero
,
et al.
Journal articles
hal-02168062v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Trabectedin in combination with doxorubicin for first-line treatment of advanced uterine or soft-tissue leiomyosarcoma (LMS-02): a non-randomised, multicentre, phase 2 trial
Patricia Pautier
,
Anne Floquet
,
Christine Chevreau
,
Nicolas Penel
,
Cécile Guillemet
,
et al.
Journal articles
hal-03623745v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Trabectedin in patients with advanced soft tissue sarcoma: A retrospective national analysis of the French Sarcoma Group
Axel Le Cesne
,
Isabelle Ray-Coquard
,
Florence Duffaud
,
Christine Chevreau
,
Nicolas Penel
,
et al.
Journal articles
hal-03623749v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
A multicenter blinded study evaluating EGFR and KRAS mutation testing methods in the clinical non-small cell lung cancer setting―IFCT/ERMETIC2 Project Part 1: Comparison of testing methods in 20 French molecular genetic National Cancer Institute platforms
Michèle Beau-Faller
,
Hélène Blons
,
Caroline Domerg
,
Dorota Gajda
,
Nicolas Richard
,
et al.
Journal articles
hal-01064291v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Interobserver agreement of qualitative analysis and tumor delineation of FMISO and FLT PET-images in lung cancer.
Sébastien Thureau
,
Philippe Chaumet Riffaud
,
Romain Modzelewski
,
Philippe Fernandez
,
Laurent Tessonnier
,
et al.
Journal of Nuclear Medicine , 2013, 54 (9), pp.1543-50
Journal articles
hal-00937372v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Cancer risks associated with germline mutations in MLH1, MSH2, and MSH6 genes in Lynch syndrome.
Valérie Bonadona
,
Bernard Bonaïti
,
Sylviane Olschwang
,
Sophie Grandjouan
,
Laetitia Huiart
,
et al.
Journal articles
hal-00780536v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Comparison of doxorubicin and weekly paclitaxel efficacy in metastatic angiosarcomas
Antoine Italiano
,
Angela Cioffi
,
Nicolas Penel
,
Matteo Giaj Levra
,
Corinne Delcambre
,
et al.
Journal articles
hal-03623788v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Etude Genesis : trois ans d'inclusion en France
Séverine Eon-Marchais
,
Morgane Marcou
,
Lucie Toulemonde
,
Marie-Gabrielle Dondon
,
Juana Beauvallet
,
et al.
EPI-CLIN - 5e Conférence Francophone d'Épidémiologie Clinique , May 2011, Marseille, France. 59 (S1), pp.S31, P5-9, 2011, Revue d'Épidémiologie et de Santé Publique.
⟨10.1016/j.respe.2011.02.050⟩
Conference poster
inserm-00609695v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Phase II study of bendamustine, bortezomib and dexamethasone as second-line treatment for elderly patients with multiple myeloma: the Intergroupe Francophone du Myelome 2009-01 trial
P. Rodon
,
C. Hulin
,
B. Pegourie
,
M. Tiab
,
B. Anglaret
,
et al.
Journal articles
hal-01116536v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Descriptive epidemiology of upper aerodigestive tract cancers in France: Incidence over 1980-2005 and projection to 2010
K. Ligier
,
A. Belot
,
G. Launoy
,
M. Velten
,
Nadine Bossard
,
et al.
Journal articles
hal-02297712v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Common variants of the BRCA1 wild-type allele modify the risk of breast cancer in BRCA1 mutation carriers.
David G Cox
,
Jacques Simard
,
Daniel Sinnett
,
Yosr Hamdi
,
Penny Soucy
,
et al.
Journal articles
hal-00790211v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Interruption versus continuation of trabectedin in patients with soft-tissue sarcoma (T-DIS): a randomised phase 2 trial
Axel Le Cesne
,
Jean-Yves Blay
,
Julien Domont
,
Emmanuelle Tresch-Bruneel
,
Christine Chevreau
,
et al.
Journal articles
hal-03623747v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Lymphoma occurring in patients over 90 years of age: characteristics, outcomes, and prognostic factors. A retrospective analysis of 234 cases from the LYSA.
A. Trebouet
,
T. Marchand
,
R. Lemal
,
Emmanuel Gyan
,
Florence Broussais-Guillaumot
,
et al.
Journal articles
inserm-00869892v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
SMARCA4 inactivation defines a group of undifferentiated thoracic malignancies transcriptionally related to BAF-deficient sarcomas
Francois Le Loarer
,
Sarah Watson
,
Gaëlle Pierron
,
Vincent Thomas de Montpreville
,
Stelly Ballet
,
et al.
Journal articles
hal-01684775v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Clinical benefits of non-taxane chemotherapies in unselected patients with symptomatic metastatic castration-resistant prostate cancer after docetaxel: the GETUG-P02 study
Florence Joly
,
Remy Delva
,
Loic Mourey
,
Emmanuel Sevin
,
Emmanuelle Bompas
,
et al.
Journal articles
hal-01939743v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Phase II trial of anticarcinoembryonic antigen pretargeted radioimmunotherapy in progressive metastatic medullary thyroid carcinoma: biomarker response and survival improvement.
Pierre-Yves Salaun
,
Loïc Campion
,
Claire Bournaud
,
Alain Faivre-Chauvet
,
Jean-Philippe Vuillez
,
et al.
Journal articles
hal-00932253v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Paclitaxel Given Once Per Week With or Without Bevacizumab in Patients With Advanced Angiosarcoma: A Randomized Phase II Trial
Isabelle Ray-Coquard
,
Julien Domont
,
Emmanuelle Tresch-Bruneel
,
Emmanuelle Bompas
,
Philippe Cassier
,
et al.
Journal articles
hal-03623742v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Phase III study of bevacizumab plus docetaxel compared with placebo plus docetaxel for the first-line treatment of human epidermal growth factor receptor 2-negative metastatic breast cancer.
David W. Miles
,
Arlene Chan
,
Luc Y. Dirix
,
Javier Cortés
,
Xavier B. Pivot
,
et al.
Journal articles
inserm-00508083v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Abiraterone acetate in patients with metastatic castration-resistant prostate cancer: Long term outcome of the Temporary Authorization for Use program in France.
Nadine Houede
,
Philippe Beuzeboc
,
Sophie Gourgou
,
Diego Tosi
,
Laura Moise
,
et al.
Journal articles
hal-03578471v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Definitive chemoradiotherapy with FOLFOX versus fluorouracil and cisplatin in patients with oesophageal cancer (PRODIGE5/ACCORD17): final results of a randomised, phase 2/3 trial
Thierry Conroy
,
Marie-Pierre Galais
,
Jean-Luc Raoul
,
Olivier Bouche
,
Sophie Gourgou-Bourgade
,
et al.
Journal articles
hal-01801252v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Description des modalités pratiques de prescription d’un facteur de croissance de la lignée granulocytaire (G-CSF) chez les patientes recevant une chimiothérapie pour un cancer du sein : étude Opaline
William Jacot
,
Eric-Charles Antoine
,
Maya Hacini
,
Cathy Giron
,
Alain Riviere
,
et al.
Journal articles
hal-02336942v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Multiple sequence variants of BRCA2 exon 7 alter splicing regulation
Pascaline Gaildrat
,
Sophie E. Krieger
,
Daniela Di Giacomo
,
Julie Abdat
,
Françoise Révillion
,
et al.
Journal articles
istex
hal-02336313v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Parenthood in Survivors of Hodgkin Lymphoma: An EORTC-GELA General Population Case-Control Study
Marleen A.E. van Der Kaaij
,
Natacha Heutte
,
Paul Meijnders
,
Edwige Abeilard-Lemoisson
,
Michele Spina
,
et al.
Journal articles
hal-02358978v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
BioCAST/IFCT-1002: epidemiological and molecular features of lung cancer in never-smokers
Sébastien Couraud
,
Pierre-Jean Souquet
,
Christophe Paris
,
Pascal Dô
,
Hélène Doubre
,
et al.
Journal articles
hal-02456986v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Professional risks when carrying out cytoreductive surgery for peritoneal malignancy with hyperthermic intraperitoneal chemotherapy (HIPEC): A French multicentric survey
G. Ferron
,
L. Simon
,
F. Guyon
,
O. Glehen
,
D. Goéré
,
et al.
Journal articles
hal-02334165v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Etude Genesis : deux ans d'inclusion !
Séverine Eon-Marchais
,
Morgane Marcou
,
Lucie Toulemonde
,
Marie-Gabrielle Dondon
,
Juana Beauvallet
,
et al.
5es Assises de Génétique Humaine et Médicale , Jan 2010, Strasbourg, France. 26 (HS1), p. 126-127, P302, 2010, Médecine Sciences: M/S
Conference poster
inserm-00456804v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Strategies of radioiodine ablation in patients with low-risk thyroid cancer.
Martin Schlumberger
,
Bogdan Catargi
,
Isabelle Borget
,
Désirée Deandreis
,
Slimane Zerdoud
,
et al.
New England Journal of Medicine , 2012, 366 (18), pp.1663-73
Journal articles
hal-00942194v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More
Sorafenib and irinotecan (NEXIRI) as second- or later-line treatment for patients with metastatic colorectal cancer and KRAS-mutated tumours: a multicentre Phase I/II trial
E. Samalin
,
O. Bouche
,
S. Thezenas
,
E. Francois
,
Antoine Adenis
,
et al.
Journal articles
hal-02181353v1
Actions
Share
Gmail
Facebook
Twitter
LinkedIn
More